Combination therapy offers quicker, less toxic eradication of hepatitis C in liver transplant patients

All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic and can lead to organ rejection. Now researchers report that use of two new oral medications post-transplant is safe and beneficial, and requires only 12 weeks of treatment.

Read the whole article on Science Daily

More from Science Daily